Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine
Clinical trial NCT02480101 · COMPLETED
Trial details
- NCT number
- NCT02480101
- Sponsor
- Research Institute of Influenza, Russia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.